VTGN Competitors & Alternatives
Compare VistaGen Therapeutics Inc with similar stocks in the same industry
Biotechnology
VTGN
Main Stock$0.25
Tradestie Score
46
Market Cap
$108.92M
Revenue Growth
0.3%
Analyst Upside
+308.2%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$21.60
|
$154.27M | - | 61 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$11.81
|
$133.50M | - | 54 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$7.29
|
$114.01M | - | 50 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$27.27
|
$110.20M | - | 54 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$5.30
|
$71.69M | - | 49 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.42
|
$67.94M | - | 52 | Compare |
|
VTVT
vTv Therapeutics Inc. Class A Common Stock
|
$32.39
|
$62.81M | - | 46 | Compare |
|
OTLK
Outlook Therapeutics, Inc. Common Stock
|
$0.91
|
$46.20M | - | 55 | Compare |
|
TENX
Tenax Therapeutics, Inc.
|
$14.33
|
$34.77M | - | 49 | Compare |
|
XBIO
Xenetic Biosciences, Inc.
|
$2.66
|
$4.78M | - | 41 | Compare |
More VTGN Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2834)
232 stocks in this industry